Argor Pharmaceuticals Private Limited
About Argor Pharmaceuticals Private Limited
Data last updated:
Argor Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 30 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2021PTC141023.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Govindasamy Arun (Managing Director) and Anbuganapathi Kaaviyaa.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. 401 Tuxedo Apartment Jawaharlal Nehru Road Velachery, Chennai, Tamil Nadu, India – 600042.
As per the financials filed for FY 2024, the company reported a revenue of ₹23 Lakh, a growth of 73% compared to the previous year. For the same year it recorded a net loss of ₹94,730 (net margin -4.1%) and EBITDA of -₹6,414 (EBITDA margin -0.3%).
Company details
Contact details
Argor Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo. 401 Tuxedo Apartment Jawaharlal Nehru Road Velachery, Chennai, Tamil Nadu, India – 600042
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Argor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Argor Pharmaceuticals Private Limited, buy the company report.
Financials of Argor Pharmaceuticals Private Limited
FY 2024 filings availableArgor Pharmaceuticals Private Limited reported revenue of ₹23 Lakh (up 73% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 73% in the latest year. EBITDA rose 97% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6,414 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹94,730 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.3% | |||
| Net Profit Margin | -4.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Argor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Argor Pharmaceuticals Private Limited
Argor Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anbuganapathi Kaaviyaa | Director | 30 Jan 2021 | 5 Years 9 Months | Current |
| Govindasamy Arun | Managing Director | 30 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Argor Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Grassindia Pharmaceuticals Private Limited | ₹23.14 Lakh (FY 2025) | -96.0% | Aurangabad, Maharashtra, India | |||
| Airmed Pharmaceuticals (India) Private Limited | ₹23.09 Lakh (FY 2020) | -47.0% | Hyderabad, Telangana, India | |||
| Argor Pharmaceuticals Private Limitedthis company | ₹23 Lakh (FY 2024) | -₹94,730 | -4.1% | 73.0% | Chennai, Tamil Nadu, India | |
| SVKC Pharmaceuticals Private Limited | ₹22.97 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Annpride Pharmaceuticals Private Limited | ₹22.83 Lakh (FY 2016) | New Delhi, Delhi, India |
To see the full peer comparison of Argor Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Argor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Argor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Argor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Argor Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anbuganapathi Kaaviyaa was appointed as Director on 30 Jan 2021.
Frequently asked questions
Argor Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 30 January 2021 (5+ years old) and is registered under CIN U51909TN2021PTC141023.
Argor Pharmaceuticals has 2 current directors:
- Govindasamy Arun - Managing Director
- Anbuganapathi Kaaviyaa - Director
The latest financial statements of Argor Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Argor Pharmaceuticals is U51909TN2021PTC141023. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Argor Pharmaceuticals was incorporated on 30 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Argor Pharmaceuticals by revenue are Grassindia Pharmaceuticals Private Limited, Airmed Pharmaceuticals (India) Private Limited, SVKC Pharmaceuticals Private Limited, Annpride Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anbuganapathi Kaaviyaa was appointed as Director on 30 Jan 2021. Govindasamy Arun was appointed as Managing Director on 30 Jan 2021.
The registered office of Argor Pharmaceuticals is at No. 401 Tuxedo Apartment Jawaharlal Nehru Road Velachery, Chennai, Tamil Nadu, India – 600042.
Argor Pharmaceuticals operates in the trading industry, in the specialty segment.
Argor Pharmaceuticals can be reached at its registered office: No. 401 Tuxedo Apartment Jawaharlal Nehru Road Velachery, Chennai, Tamil Nadu, India – 600042.
Argor Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
